Dr. Gueble is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
20 York St
New Haven, CT 06510Phone+1 203-688-4242
Education & Training
Yale-New Haven Medical CenterResidency, Radiation Oncology, 2019 - 2023
Yale School of MedicineClass of 2018
Certifications & Licensure
CT State Medical License 2018 - 2025
Publications & Presentations
PubMed
- The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastoma.Matthew McCord, Thomas Sears, Wenxia Wang, Rahul Chaliparambil, Shejuan An
Neuro-Oncology. 2024-12-10 - Mechanism of Action of KL-50, a Candidate Imidazotetrazine for the Treatment of Drug-Resistant Brain Cancers.Eric D Huseman, Anna Lo, Olga Fedorova, James L Elia, Susan E Gueble
Journal of the American Chemical Society. 2024-07-10 - 3 citationsThe Role of PARP Inhibitors in Patients with Primary Malignant Central Nervous System Tumors.Susan E Gueble, Juan C Vasquez, Ranjit S Bindra
Current Treatment Options in Oncology. 2022-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
